We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $696M
1-Year Est. Return 17.86%
This Fund
S&P 500
This Quarter Est. Return
+1.98%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
–
AUM
$363M
AUM Growth
+$9.88M
Cap. Flow
+$7.65M
Cap. Flow %
2.11%
Top 10 Hldgs %
30.44%
Holding
74
New
3
Increased
41
Reduced
28
Closed
1

Top Buys

1
AMGN icon
Amgen
AMGN
+$8.81M
2
DLX icon
Deluxe
DLX
+$1.07M
3
KDP icon
Keurig Dr Pepper
KDP
+$716K
4
AAPL icon
Apple
AAPL
+$620K
5
GILD icon
Gilead Sciences
GILD
+$556K

Top Sells

1
CLB icon
Core Laboratories
CLB
+$1.18M
2
DHR icon
Danaher
DHR
+$961K
3
SYK icon
Stryker
SYK
+$133K
4
MSFT icon
Microsoft
MSFT
+$130K
5
MDT icon
Medtronic
MDT
+$117K

Sector Composition

1 Consumer Discretionary 19.18%
2 Industrials 18.13%
3 Technology 17.43%
4 Healthcare 13.55%
5 Consumer Staples 12.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VAR
26
DELISTED
Varian Medical Systems, Inc.
VAR
$6.88M 1.9%
78,885
-161
-0.2% -$13.1K
AME icon
27
Ametek
AME
$54.3B
$6.56M 1.81%
137,232
+230
+0.2% +$11K
CBRL icon
28
Cracker Barrel
CBRL
$1.18B
$6.46M 1.78%
48,893
+1,324
+3% +$203K
DLTR icon
29
Dollar Tree
DLTR
$24.5B
$6.36M 1.75%
80,569
+531
+0.7% +$47.8K
EV
30
DELISTED
Eaton Vance Corp.
EV
$5.95M 1.64%
152,286
+2,502
+2% +$95.7K
ORLY icon
31
O'Reilly Automotive
ORLY
$70.7B
$5.83M 1.61%
312,360
+24,780
+9% +$464K
PII icon
32
Polaris
PII
$4.1B
$5.59M 1.54%
72,233
+1,180
+2% +$102K
SLGN icon
33
Silgan Holdings
SLGN
$4.96B
$5.33M 1.47%
210,812
+822
+0.4% +$20.5K
SYK icon
34
Stryker
SYK
$122B
$5.06M 1.39%
43,438
-1,141
-3% -$133K
NVO
35
Novo Nordisk
NVO
$223B
$4.92M 1.36%
236,702
+17,542
+8% +$435K
K
36
DELISTED
Kellanova
K
$4.84M 1.34%
66,601
-1,431
-2% -$109K
CNI icon
37
Canadian National Railway
CNI
$77.8B
$4.84M 1.33%
73,980
+2,125
+3% +$134K
ABBV icon
38
AbbVie
ABBV
$451B
$4.22M 1.16%
66,890
-1,175
-2% -$76.1K
COL
39
DELISTED
Rockwell Collins
COL
$3.47M 0.96%
41,185
+125
+0.3% +$10.5K
HBI
40
DELISTED
Hanesbrands
HBI
$3.13M 0.86%
123,782
+7,329
+6% +$193K
PDCO
41
DELISTED
Patterson Companies, Inc.
PDCO
$2.93M 0.81%
63,837
-1,400
-2% -$66.2K
VSTO
42
DELISTED
Vista Outdoor Inc.
VSTO
$2.92M 0.81%
73,326
-2,596
-3% -$115K
KMB icon
43
Kimberly-Clark
KMB
$35.8B
$2.91M 0.8%
23,107
-44
-0.2% -$5.69K
LH icon
44
Labcorp
LH
$23.1B
$2.9M 0.8%
24,515
+81
+0.3% +$9.54K
OA
45
DELISTED
Orbital ATK, Inc.
OA
$2.66M 0.73%
34,910
-1,144
-3% -$91.1K
DHR icon
46
Danaher
DHR
$144B
$2.54M 0.7%
36,531
-13,558
-27% -$961K
LLY icon
47
Eli Lilly
LLY
$1.05T
$2.35M 0.65%
29,326
-1,304
-4% -$104K
EXPD icon
48
Expeditors International
EXPD
$23.8B
$2.29M 0.63%
44,442
+719
+2% +$36.4K
TECH icon
49
Bio-Techne
TECH
$11.2B
$2.07M 0.57%
75,688
-1,000
-1% -$27.5K
MDT icon
50
Medtronic
MDT
$106B
$1.94M 0.53%
22,432
-1,342
-6% -$117K
1
2
3

Similar funds

AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
FCM
Fourpath Capital Management Oklahoma City, Oklahoma $697M AUM 29.98% 1-Year Est. Return
GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $697M AUM 23.83% 1-Year Est. Return
BBPWM
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $696M AUM 17.73% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

JLB & Associates's Q3 2016 Portfolio in Review

As of Q3 2016, JLB & Associates held 74 positions worth $363M, up 2.8% from $353M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

JLB & Associates's Q3 2016 filing shows 3 new, 41 increased, 28 reduced and 1 closed positions. Its largest new stake was Amgen: 52,120 shares worth $8.69M. The largest sale was Core Laboratories, an estimated $1.18M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 19% a quarter earlier, followed by Industrials and Technology.

  • JLB & Associates's largest Q3 2016 buy was Amgen: 52,120 shares worth $8.69M.
  • JLB & Associates added most to Deluxe in Q3 2016, an estimated $1.07M increase.
  • JLB & Associates's biggest Q3 2016 reduction was Core Laboratories, cutting an estimated $1.18M.
  • JLB & Associates's ten largest holdings make up 30% of its $363M portfolio in Q3 2016.
  • JLB & Associates opened 3 new positions and closed 1 in Q3 2016.
  • JLB & Associates's portfolio value rose 2.8% quarter-over-quarter to $363M.

Based on JLB & Associates's 13F filing for Q3 2016, filed 26 Oct 2016.